An investigation of position 3 in arginine vasopressin (AVP)
暂无分享,去创建一个
S. Stoev | M. Manning | A. Olma | W. Sawyer | W. Y. Chan | L. Cheng | N. Wo | Wieslaw A. Klis
[1] G. Kupryszewski,et al. Influence of L-naphthylalanine in position 3 of AVP and its analogues on their pharmacological properties. , 2009, The journal of peptide research : official journal of the American Peptide Society.
[2] S. Stoev,et al. Position Three in Vasopressin Antagonist Tolerates Conformationally Restricted and Aromatic Amino Acid Substitutions: A Striking Contrast with Vasopressin Agonists , 1997, Journal of peptide science : an official publication of the European Peptide Society.
[3] S. Stoev,et al. An exploration of the effects of L‐ and D‐tetrahydroisoquinoline‐3‐carboxylic acid substitutions at positions 2,3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin , 1995, Journal of peptide science : an official publication of the European Peptide Society.
[4] M. Lebl,et al. CRC handbook of neurohypophyseal hormone analogs , 1987 .
[5] M. Ferger,et al. Synthesis and some pharmacological properties of (3-beta-(2-thienyl)-L-alanine)-8-lysine-vasopressin. , 1975, Journal of medicinal chemistry.